Position in DNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$306,500
-$109,000 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EDGEWOOD MANAGEMENT LLC holds $409,477,253 across 8 Biotechnology names. DNA ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
905,129 | $404,176,303 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
25,000 | $1,567,500 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
35,000 | $1,184,050 | |
| 4 | ARMP |
Armata Pharmaceuticals, Inc.
|
100,000 | $1,024,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
10,000 | $564,900 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
50,000 | $486,000 | |
| 7 | DNA |
Ginkgo Bioworks Holdings, Inc.
This page
|
50,000 | $306,500 | |
| 8 | SEER |
Seer, Inc.
|
100,000 | $168,000 |
All Filings in DNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $306,500 | 50,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $415,500 | 50,000 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||